Non-HDL cholesterol is a single number that captures all the “bad” cholesterol circulating in your blood. You get it by subtracting your HDL (the protective cholesterol) from your total cholesterol. What remains represents the combined cholesterol carried by every type of particle that can build up in your artery walls, making it a broader and often more useful measure than LDL alone.
How Non-HDL Cholesterol Is Calculated
The formula is simple: total cholesterol minus HDL cholesterol equals non-HDL cholesterol. If your total cholesterol is 210 mg/dL and your HDL is 55 mg/dL, your non-HDL cholesterol is 155 mg/dL. You don’t need a separate test for it. Any standard lipid panel gives your doctor the two numbers needed to calculate it.
One practical advantage: non-HDL cholesterol stays accurate whether or not you fasted before the blood draw. LDL cholesterol, by contrast, is typically estimated using a formula that becomes less reliable when triglycerides are elevated or when you’ve recently eaten. Recent expert recommendations support non-fasting lipid panels partly because non-HDL cholesterol holds up well without fasting, improving convenience for patients and clinics alike.
What It Includes That LDL Doesn’t
LDL cholesterol gets most of the attention, but it only accounts for one type of artery-clogging particle. Non-HDL cholesterol bundles together LDL plus VLDL (very-low-density lipoprotein), intermediate-density lipoprotein, and lipoprotein(a). All of these particles carry a protein called apolipoprotein B on their surface, which is what allows them to penetrate artery walls and fuel plaque buildup.
This matters because people with normal LDL can still have elevated levels of these other particles, especially if triglycerides are high. Someone with an LDL of 95 mg/dL might feel reassured, but if their non-HDL is 145 mg/dL, the gap reveals a significant load of additional harmful particles that LDL alone would miss. That extra cholesterol doesn’t show up on the LDL line of a lab report, but it still contributes to cardiovascular risk.
Why It Predicts Heart Disease Better Than LDL
A growing body of evidence shows non-HDL cholesterol is a stronger predictor of cardiovascular disease than LDL cholesterol. This is particularly true for people already taking statins. Research published in The Lancet found that non-HDL cholesterol better reflects the residual cardiovascular risk in statin-treated patients, even when LDL has been brought below target levels. The reason: statins effectively lower LDL, but they don’t eliminate all atherogenic particles equally. Non-HDL captures what’s left behind.
The European Society of Cardiology has noted that apolipoprotein B, which tracks closely with non-HDL cholesterol, is a more accurate marker of cardiovascular risk and treatment adequacy than LDL alone. Non-HDL cholesterol serves as a practical stand-in for apoB because it correlates strongly with it and doesn’t require a separate, less commonly ordered blood test.
Target Levels Based on Your Risk
The 2026 ACC/AHA guidelines set non-HDL cholesterol goals based on how likely you are to have a cardiovascular event in the next ten years. The targets get progressively tighter as risk increases.
- Borderline or intermediate risk (3% to under 10% ten-year risk): non-HDL below 130 mg/dL
- High risk (10% or greater ten-year risk): non-HDL below 100 mg/dL
- Established heart disease, not very high risk: non-HDL below 100 mg/dL
- Established heart disease, very high risk: non-HDL below 85 mg/dL
For general context, a non-HDL below 130 mg/dL is a reasonable goal for most adults without heart disease. If your number is above 160 mg/dL, that signals elevated atherogenic cholesterol regardless of what your LDL reads.
Lifestyle Changes That Lower Non-HDL
Because non-HDL cholesterol includes particles driven by both dietary fat and triglycerides, lifestyle changes can move the needle meaningfully. The National Heart, Lung, and Blood Institute recommends a combination of dietary shifts, physical activity, and weight management.
On the dietary side, reducing saturated fat is the most impactful single change. Replacing it with unsaturated fats from sources like olive oil, nuts, and avocados helps lower the cholesterol content of atherogenic particles. Adding soluble fiber from oats, beans, and fruits pulls cholesterol out of circulation through the digestive tract. Plant stanols and sterols, found naturally in whole grains, legumes, and certain oils, block cholesterol absorption in the gut and can reduce levels by a modest but consistent amount.
Regular physical activity helps primarily by raising HDL and lowering triglycerides, which reduces the VLDL component of non-HDL cholesterol. You don’t need intense exercise. Consistent moderate activity, like brisk walking most days, improves the overall lipid profile. Losing excess weight amplifies all of these effects. Even a modest reduction in body weight improves cholesterol, triglycerides, blood pressure, and blood sugar simultaneously.
How Medications Affect Non-HDL
When lifestyle changes aren’t enough, cholesterol-lowering medications target the particles that make up non-HDL cholesterol. Statins remain the first-line treatment, typically reducing LDL by 35% to 55%, with proportional effects on non-HDL. Because statins also modestly lower triglyceride-rich particles, their impact on non-HDL cholesterol can sometimes exceed their impact on LDL alone.
For people who don’t reach their goals on statins, additional medications can be layered on. Ezetimibe, which blocks cholesterol absorption in the intestine, adds another 18% to 25% reduction. PCSK9 inhibitors, given as injections every two to four weeks, are the most powerful option, cutting LDL by 40% to 65%. Bempedoic acid, a newer oral medication, provides an additional 20% to 28% reduction and is sometimes used by people who can’t tolerate statins.
The key insight from current guidelines is that non-HDL cholesterol serves as a treatment target alongside LDL. If your LDL is at goal but your non-HDL remains elevated, that residual gap, usually driven by high triglycerides, signals ongoing risk that may warrant additional attention through either lifestyle intensification or medication adjustment.
How to Use Your Non-HDL Number
Next time you get a lipid panel, look beyond the LDL line. Subtract your HDL from total cholesterol yourself if the lab report doesn’t list non-HDL explicitly. Compare it against the targets above based on your risk category. If your LDL looks fine but your non-HDL is 30 or more points higher, that gap likely reflects elevated triglycerides and VLDL, which deserve their own attention through diet, exercise, weight loss, or medication.
Non-HDL cholesterol gives you a more complete picture of your cardiovascular risk in a single, easy-to-calculate number. It works whether or not you fasted, it stays reliable on statin therapy, and it captures harmful particles that LDL misses. For most people, it’s the most practical cholesterol number to track over time.